Gracure Pharmaceuticals Limited — Chlorpheniramine Exporter Profile
Indian Pharmaceutical Exporter · #7 for Chlorpheniramine · $990.1K export value · DGFT Verified
Gracure Pharmaceuticals Limited is the #7 Indian exporter of Chlorpheniramine with $990.1K in export value and 70 verified shipments. Gracure Pharmaceuticals Limited holds a 2.1% market share in Chlorpheniramine exports across 4 countries. The company exports 17 pharmaceutical products worth $28.1M across 9 therapeutic categories.
Gracure Pharmaceuticals Limited — Chlorpheniramine Export Profile: Buyers & Destinations
Where Does Gracure Pharmaceuticals Limited Export Chlorpheniramine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| BELGIUM | $906.2K | 62 | 93.6% |
| MOZAMBIQUE | $30.5K | 6 | 3.2% |
| GERMANY | $17.1K | 1 | 1.8% |
| TANZANIA | $14.4K | 1 | 1.5% |
Gracure Pharmaceuticals Limited exports Chlorpheniramine to 4 countries. The largest destination is BELGIUM accounting for 93.6% of Gracure Pharmaceuticals Limited's Chlorpheniramine shipments, followed by MOZAMBIQUE (3.2%) and GERMANY (1.8%). These destinations reflect Gracure Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Chlorpheniramine from Gracure Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| GENERICS & SPECIALITIES LIMITADA | MOZAMBIQUE | $30.5K | 6 |
| PHILCO PHARMA EKINH CARSTEN PHILIPPS BARKHOLT | GERMANY | $17.1K | 1 |
| H H PHARMA LTD RWANDA | TANZANIA | $14.4K | 1 |
Gracure Pharmaceuticals Limited supplies Chlorpheniramine to 3 buyers globally. The largest buyer is GENERICS & SPECIALITIES LIMITADA (MOZAMBIQUE), followed by PHILCO PHARMA EKINH CARSTEN PHILIPPS BARKHOLT (GERMANY) and H H PHARMA LTD RWANDA (TANZANIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Chlorpheniramine Export Value and How Much Does Gracure Pharmaceuticals Limited Contribute?
India exported $18.9M worth of Chlorpheniramine through 3,434 shipments from 474 suppliers to 137 countries, serving 899 buyers globally. Gracure Pharmaceuticals Limited contributes $990.1K to this total, accounting for 2.1% of India's Chlorpheniramine exports. Gracure Pharmaceuticals Limited ships Chlorpheniramine to 4 countries through 3 buyers.
What Is the Average Shipment Value for Gracure Pharmaceuticals Limited's Chlorpheniramine Exports?
Gracure Pharmaceuticals Limited's average Chlorpheniramine shipment value is $14.1K per consignment, based on 70 shipments totaling $990.1K. The largest destination is BELGIUM (93.6% of Gracure Pharmaceuticals Limited's Chlorpheniramine exports).
How Does Gracure Pharmaceuticals Limited Compare to Other Indian Chlorpheniramine Exporters?
Gracure Pharmaceuticals Limited ranks #7 among 474 Indian Chlorpheniramine exporters with a 2.1% market share. The top 3 exporters are COMBITIC GLOBAL CAPLET PRIVATE LIMITED ($6.1M), ADCOCK INGRAM LIMITED ($2.6M), SOCOMED PHARMA PRIVATE LIMITED ($2.4M). Gracure Pharmaceuticals Limited processed 70 shipments to 4 destination countries.
What Chlorpheniramine Formulations Does Gracure Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| FEBRILEX JUNIOR SYRUP 150ML PARACETAMOLBP 125 MG CHLORPHENIRAMINE MALEATE BP1MG | $120.2K | 4 |
| FEBRILEX JUNIOR SYRUP -150ML PARACETAMOL BP 125 MG,CHLORPHENIRAMINE MALEATE BP1MG ) | $64.8K | 2 |
| FEBRILEX + SYRUP -150ML(PARACETAMOL BP125MG,DEXTROMETHORPHAN HYD.EQ TO DEXTROMETHORPHAN5MG,CHLORPHENIRAMINE MALEATE 1MG | $59.5K | 3 |
| FEBRILEX + SYRUP-150ML (PARACETAMOL BP125 MGDEXTROMETHORPHAN HYDROBROMIDE EQ TODEXTR. 5MGCHLORPHENIRAMINE MALEATE 1MGNOS | $59.4K | 3 |
| FEBRILEX JUNIOR SYRUP 150ML PARACETAMOL BP 125 MG CHLORPHENIRAMINE MALEATE BP1MG | $57.8K | 2 |
| FEBRILEX JUNIOR SYRUP -150ML PARACETAMOLBP 125MG, CHLORPHENIRAMINE MALEATE BP1MG) | $50.0K | 1 |
| FEBRILEX JUNIOR SYRUP -150ML PARACETAMOLBP 125MG, CHLORPHENIRAMINE MALEATE BP 1MG) | $50.0K | 1 |
| FEBRILEX SYRUP 150ML PARACETAMOL BP125 MG DEXTROMETHORPHAN HYDROBROMIDE EQ TO DEXTROMETHORPHAN5MG CHLORPHENIRAMINE | $45.1K | 1 |
| FEBRILEX JUNIOR SYRUP-150ML PARACETAMOLBP125MG(CHLORPHENIRAMINE MAL.BP1MG)B.N.AS240060A TOAS240062A,M.D.02/24,E.D.01/27 | $44.7K | 1 |
| FEBRILEX JUNIOR SYRUP-150ML(PARACETAMOLBP 125MG,CHLORPHENIRAMINE MALEATE BP 1MG)B.NO.AS240063A TO AS240065A, | $44.7K | 1 |
Gracure Pharmaceuticals Limited exports 43 distinct Chlorpheniramine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is FEBRILEX JUNIOR SYRUP 150ML PARACETAMOLBP 125 MG CHLORPHENIR with 4 shipments worth $120.2K.
Regulatory Requirements: Exporting Chlorpheniramine to Key Markets
What Gracure Pharmaceuticals Limited must comply with to export Chlorpheniramine to its top destination countries
Germany — BfArM/EMA
Approval Process
Marketing Authorisation via Decentralized or Mutual Recognition Procedure under EU Directive 2001/83/EC. CTD Module 1–5 dossier required.
Timeline: 12–18 months via Decentralized Procedure
GMP & Export Requirements
EU GMP (EudraLex Vol. 4); GMP certificate from EU competent authority; WHO Prequalification accepted as supporting evidence
Certificate of Pharmaceutical Product (CPP) from CDSCO; Written Confirmation for API export per EU requirements; EU FMD serialization mandatory
Note: Indian manufacturers must hold EU GMP certificate. EU Falsified Medicines Directive (FMD) serialization and tamper-evident packaging mandatory.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Gracure Pharmaceuticals Limited Compare to Nearest Chlorpheniramine Exporters?
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | SOCOMED PHARMA PRIVATE LIMITED | $2.4M | 125 | 12 | $19.2K |
| 6 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $1.1M | 61 | 4 | $18.8K |
| 7 | GRACURE PHARMACEUTICALS LIMITED ★ | $990.1K | 70 | 4 | $14.1K |
| 2 | MMC HEALTH CARE LIMITED | $950.0K | 19 | 3 | $50.0K |
| 8 | MICRO LABS LIMITED | $800.0K | 16 | 3 | $50.0K |
Gracure Pharmaceuticals Limited ranks #7 among 474 Indian Chlorpheniramine exporters. Average shipment value of $14.1K compared to the market average of $39.8K. The closest competitors by value are SOCOMED PHARMA PRIVATE LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED.
Which Indian Ports Ship Chlorpheniramine Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 406 | 11.8% |
| JNPT/ NHAVA SHEVA SEA | 326 | 9.5% |
| JNPT | 291 | 8.5% |
| SAHAR AIR | 196 | 5.7% |
| BANGALORE ICD | 157 | 4.6% |
| AHEMDABAD ICD | 140 | 4.1% |
| BANGALORE ICD (INWFD6) | 121 | 3.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 120 | 3.5% |
Geopolitical & Trade Policy Impact on Gracure Pharmaceuticals Limited's Chlorpheniramine Exports
Recent geopolitical tensions, particularly in the Middle East, have significantly impacted global shipping routes. The Red Sea crisis and Houthi attacks have led to increased shipping costs and extended transit times for Indian exporters. Major carriers have suspended or restricted transits through the Red Sea–Suez Canal corridor, resulting in transit times extending by 10–20 days and freight rates rising by 40–50% on key India–Europe routes. (livemint.com)
For Gracure Pharmaceuticals, which relies heavily on maritime routes for its exports, these disruptions pose challenges in maintaining timely deliveries and managing increased operational costs. Additionally, the U.S.–India diplomatic and trade crisis, marked by the imposition of tariffs on Indian exports, further complicates the export landscape. The U.S. administration imposed a 25% "reciprocal" tariff, followed by an additional 25% penalty tied to India's continued imports of Russian oil, bringing the total duty to 50%. (en.wikipedia.org) These developments necessitate strategic adjustments to mitigate potential revenue losses and sustain market competitiveness.
Gracure Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. Gracure Pharmaceuticals has secured approvals and clearances from various international regulatory bodies, reflecting its commitment to quality and safety. However, evolving regulations, such as the European Union's falsified medicines directive, impose additional compliance requirements. Adhering to these standards is crucial for maintaining market access and consumer trust.
Furthermore, the U.S. Food and Drug Administration (FDA) has intensified scrutiny of foreign pharmaceutical manufacturers. Ensuring compliance with FDA regulations is essential for Gracure to sustain and expand its presence in the lucrative U.S. market.
About Gracure Pharmaceuticals Limited
Gracure Pharmaceuticals Limited exports 17 products worth $28.1M. Beyond Chlorpheniramine, top products include Tramadol, Albendazole, Folic, Melatonin, Celecoxib. View the complete Gracure Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Chlorpheniramine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Chlorpheniramine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Gracure Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 70 individual customs records matching Gracure Pharmaceuticals Limited exporting Chlorpheniramine, covering 43 formulations to 4 countries via 3 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 137+ countries, 899+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Chlorpheniramine Export Data from Gracure Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Gracure Pharmaceuticals Limited's Chlorpheniramine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Gracure Pharmaceuticals Limited
Full Company Profile →
17 products · $28.1M total trade · 9 categories
Chlorpheniramine Stats
Company Overview
Top Products by Gracure Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Gracure Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Chlorpheniramine. For current shipment-level data, contact TransData Nexus.